Benitec Biopharma Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-14: Form 10-K; Period of report 2026-06-30; Description 10-K; Document bntc-20260630.htm.
- 2025-09-22: Form 10-K; Period of report 2025-06-30; Description 10-K; Document d57150d10k.htm.
- 2024-09-26: Form 10-K; Period of report 2024-06-30; Description 10-K; Document d640181d10k.htm.
- 2023-09-21: Form 10-K; Period of report 2023-06-30; Description 10-K; Document d549728d10k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-14 | 10-K | 2026-06-30 | 10-K | bntc-20260630.htm |
| 2025-09-22 | 10-K | 2025-06-30 | 10-K | d57150d10k.htm |
| 2024-09-26 | 10-K | 2024-06-30 | 10-K | d640181d10k.htm |
| 2023-09-21 | 10-K | 2023-06-30 | 10-K | d549728d10k.htm |
| 2022-09-02 | 10-K | 2022-06-30 | 10-K | d360350d10k.htm |
| 2021-09-20 | 10-K | 2021-06-30 | 10-K | d182332d10k.htm |
| 2020-09-23 | 10-K | 2020-06-30 | FORM 10-K | d899221d10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |